Joshua Hopkins
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.6% — the pattern of someone who eats at a lot of different presentations.
Across 232 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$484
- GSK$484
- Abbott$429
- AbbVie$383
- Boehringer Ingelheim$285
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$269
- plus $2K from 19 others
What the payments were for
- Food & beverage$3,824100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 29 | $484 |
| GSK | 34 | $484 |
| Abbott | 21 | $429 |
| AbbVie | 23 | $383 |
| Boehringer Ingelheim | 18 | $285 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $269 |
| AstraZeneca | 15 | $257 |
| Lilly USA, LLC | 11 | $182 |
| Pfizer | 11 | $148 |
| Amgen | 8 | $128 |
| Verona Pharma, Inc. | 4 | $100 |
| Amarin Pharma, Inc. | 6 | $90 |
| Idorsia Pharmaceuticals US Inc | 5 | $82 |
| E.r. Squibb & Sons, L.L.C. | 4 | $63 |
| Dexcom, Inc. | 4 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Bayer | 3 | $54 |
| Almatica Pharma LLC | 3 | $54 |
| Nestle Healthcare Nutrition Inc. | 2 | $45 |
| Novartis | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $36 |
| Merck | 2 | $28 |
| Dompe US, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $16 |
How this compares
$3,835 in reported general payments places this provider in the 80th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 139 | $175,711 |
| MounjaroTirzepatide | 124 | $134,401 |
| FarxigaDapagliflozin Propanediol | 87 | $77,339 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 91 | $68,725 |
| EliquisApixaban | 79 | $62,625 |
| TrulicityDulaglutide | 59 | $60,744 |
| LinzessLinaclotide | 70 | $49,092 |
| RybelsusSemaglutide | 33 | $47,941 |
| JanuviaSitagliptin Phosphate | 38 | $31,218 |
| XareltoRivaroxaban | 36 | $30,137 |
| EntrestoSacubitril/Valsartan | 31 | $23,626 |
| JardianceEmpagliflozin | 22 | $22,910 |
| GemtesaVibegron | 38 | $21,288 |
| Spiriva RespimatTiotropium Bromide | 29 | $20,034 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $18,392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $484 | $223,653172 claims |
| Lilly USA, LLCMounjaro, Trulicity | $182 | $195,145183 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort | $257 | $121,411174 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $484 | $74,855102 claims |
| PfizerEliquis | $148 | $62,62579 claims |
| MerckJanuvia, Janumet, Lagevrio (Eua), Belsomra | $28 | $56,14973 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat | $285 | $52,11669 claims |
| AbbVieLinzess | $383 | $49,09270 claims |
| NovartisEntresto | $40 | $23,62631 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $61 | $21,28838 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $269 | $12,53515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 233 medical providers in West Virginia.
Other medical in Welch
- Michael WalkerWelch$3K
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.